RecruitingNCT06758960

Analysis of Biological Progression and Regression of HELLP Syndrome in Time

Biological Evolution of HELLP Syndrome


Sponsor

CHU Mohammed VI Marrakech

Enrollment

70 participants

Start Date

Jul 1, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

Prospective observational study about progression and regression of biological parameters of HELLP syndrome


Eligibility

Sex: FEMALE

Plain Language Summary

Simplified for easier understanding

This study is analyzing blood test results over time in pregnant women admitted to intensive care with HELLP syndrome — a serious complication of pregnancy involving abnormal blood clotting, liver damage, and a low platelet count — to better understand how this condition develops and resolves. **You may be eligible if...** - You are a pregnant woman admitted to a maternal ICU with HELLP syndrome based on blood test findings **You may NOT be eligible if...** - Your blood abnormalities are caused by a different condition, such as a blood vessel disorder (microangiopathy) or leukemia - You have received plasma exchange therapy Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

CHU Mohammed VI of Marrakech

Marrakesh, Marrakech - Safi, Morocco

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06758960


Related Trials